In a previous study has shown that administration of JNK inhibitor 8 (JNK‐in‐8) alleviates lipopolysaccharide (LPS)‐induced acute lung injury by suppressing JNK/NF‐κB signaling in LPS‐induced ARDS rats (Du et al., 2021). Here, MAPK8 is linked to acute respiratory distress syndrome.